亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Risk of Abemaciclib-induced Liver Injury in Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer: A Retrospective Analysis

医学 内科学 中止 芳香化酶抑制剂 乳腺癌 肿瘤科 富维斯特朗 优势比 转移性乳腺癌 相伴的 危险系数 癌症 回顾性队列研究 胃肠病学 三苯氧胺 置信区间
作者
Azusa Taniguchi,Nobuyoshi Kittaka,Haruka Kanaoka,Satomi Nakajima,Yuri Oyama,Yukiko Seto,AI SOMA,Hiroki Kusama,Noriyuki Watanabe,Saki Matsui,Minako Nishio,Fumie Fujisawa,Takahiro Nakayama
出处
期刊:Anticancer Research [International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts]
卷期号:42 (12): 6027-6035 被引量:2
标识
DOI:10.21873/anticanres.16114
摘要

The efficacy of endocrine therapy combined with abemaciclib for hormone receptor-positive, HER2-negative metastatic breast cancer has been established through pivotal clinical trials. However, abemaciclib-induced liver injury (AILI) can be a cause for dose reduction or discontinuation. Therefore, it is critical to understand the risk factors for AILI.This retrospective study analyzed data from patients who had received abemaciclib combined with endocrine therapy for metastatic breast cancer as first- or second-line therapy at our hospital between December 2018 and October 2021. Relevant data were extracted from their medical records. Logistic regression analysis was performed to identify characteristics associated with AILI.Of the 52 eligible patients, 12 (23%) received an aromatase inhibitor (AI), and 40 (77%) received fulvestrant, concomitantly with abemaciclib. Fifteen (29%) of the patients developed liver injury after starting abemaciclib. Univariate analysis revealed the following risk factors for AILI: age ≥65 years (p=0.047), fatty liver disease (p=0.047), and concomitant use of an AI (p=0.002). Concomitant use of an AI was identified by multivariate analysis as an independent risk factor for AILI [odds ratio (OR)=10.23, 95% confidence interval (CI)=2.02-51.91, p=0.005].Concomitant use of an AI could be the most significant factor associated with increased risk of AILI. Future research on the mechanism by which the use of an AI plus abemaciclib can cause liver injury, and prospective studies to validate our findings regarding AILI risk factors, are warranted.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李李发布了新的文献求助10
2秒前
科研通AI5应助李李采纳,获得10
9秒前
爱笑的毛衣完成签到,获得积分10
11秒前
太叔丹翠完成签到 ,获得积分10
13秒前
沉默白猫完成签到 ,获得积分10
14秒前
18秒前
sowhat完成签到 ,获得积分10
21秒前
孙老师完成签到 ,获得积分10
26秒前
盛事不朽完成签到 ,获得积分10
26秒前
28秒前
科研通AI2S应助科研通管家采纳,获得10
29秒前
FashionBoy应助科研通管家采纳,获得10
29秒前
羞涩的傲菡完成签到,获得积分10
41秒前
41秒前
Hung发布了新的文献求助10
46秒前
53秒前
Lyncon完成签到,获得积分10
57秒前
Milton_z完成签到 ,获得积分0
1分钟前
Hung完成签到,获得积分10
1分钟前
tingyeh完成签到,获得积分10
1分钟前
1分钟前
两个我完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
务实书包完成签到,获得积分10
1分钟前
1分钟前
1分钟前
2分钟前
英姑应助科研通管家采纳,获得10
2分钟前
打打应助科研通管家采纳,获得10
2分钟前
2分钟前
24124f发布了新的文献求助10
2分钟前
2分钟前
2分钟前
2分钟前
大闲鱼铭一完成签到 ,获得积分10
2分钟前
干净涵梅发布了新的文献求助10
3分钟前
舒适的藏花完成签到 ,获得积分10
3分钟前
3分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990049
求助须知:如何正确求助?哪些是违规求助? 3532108
关于积分的说明 11256354
捐赠科研通 3270976
什么是DOI,文献DOI怎么找? 1805166
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809228